arbiter
JournalsAccount

The 340B Drug Pricing Program, Hospital Prices, and Competition in Commercial Markets

Sunita M. Desai et al.

Health Services Research2026https://doi.org/10.1111/1475-6773.70085article
AJG 3ABDC A
Weight
0.50

Abstract

Hospital 340B eligibility reduced commercial drug prices only in competitive markets. These findings suggest that market competition is critical for ensuring that policy-driven hospital cost savings are shared with payers and patients.

Open via your library →

Cite this paper

https://doi.org/https://doi.org/10.1111/1475-6773.70085

Or copy a formatted citation

@article{sunita2026,
  title        = {{The 340B Drug Pricing Program, Hospital Prices, and Competition in Commercial Markets}},
  author       = {Sunita M. Desai et al.},
  journal      = {Health Services Research},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1111/1475-6773.70085},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

The 340B Drug Pricing Program, Hospital Prices, and Competition in Commercial Markets

Flags are reviewed by the Arbiter methodology team within 5 business days.

Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.